AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
AngioDynamics (NASDAQ: ANGO), a medical technology company specializing in vascular health and cancer treatment solutions, has announced its participation in the upcoming Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference.
The company's leadership team, including President and CEO Jim Clemmer and EVP/CFO Stephen Trowbridge, will deliver a presentation on Monday, March 17, 2025, at 12:00 p.m. ET. Investors and interested parties can access the live webcast through the 'Investors' section of AngioDynamics' website at www.angiodynamics.com, with a replay option available after the event.
AngioDynamics (NASDAQ: ANGO), un'azienda di tecnologia medica specializzata in soluzioni per la salute vascolare e il trattamento del cancro, ha annunciato la sua partecipazione alla prossima 35ª Conferenza Virtuale Annuale MedTech e Servizi di Oppenheimer.
Il team dirigenziale dell'azienda, incluso il Presidente e CEO Jim Clemmer e il EVP/CFO Stephen Trowbridge, presenterà un intervento lunedì 17 marzo 2025, alle 12:00 ET. Gli investitori e le parti interessate possono accedere alla diretta web attraverso la sezione 'Investitori' del sito web di AngioDynamics all'indirizzo www.angiodynamics.com, con un'opzione di replay disponibile dopo l'evento.
AngioDynamics (NASDAQ: ANGO), una empresa de tecnología médica especializada en soluciones de salud vascular y tratamiento del cáncer, ha anunciado su participación en la próxima 35ª Conferencia Virtual Anual de MedTech y Servicios de Oppenheimer.
El equipo de liderazgo de la empresa, incluyendo al Presidente y CEO Jim Clemmer y al EVP/CFO Stephen Trowbridge, ofrecerá una presentación el lunes 17 de marzo de 2025, a las 12:00 p.m. ET. Los inversores y partes interesadas pueden acceder a la transmisión en vivo a través de la sección 'Inversores' del sito web de AngioDynamics en www.angiodynamics.com, con una opción de repetición disponible después del evento.
AngioDynamics (NASDAQ: ANGO), 혈관 건강 및 암 치료 솔루션에 특화된 의료 기술 회사가 다가오는 Oppenheimer 제35회 연례 헬스케어 MedTech 및 서비스 가상 회의에 참여한다고 발표했습니다.
회사의 리더십 팀, 즉 회장 겸 CEO인 Jim Clemmer와 EVP/CFO인 Stephen Trowbridge가 2025년 3월 17일 월요일, 오후 12:00 ET에 발표를 진행할 예정입니다. 투자자 및 관심 있는 당사자는 AngioDynamics 웹사이트의 '투자자' 섹션을 통해 생중계에 접속할 수 있으며, 행사 후 재생 옵션도 제공됩니다.
AngioDynamics (NASDAQ: ANGO), une entreprise de technologie médicale spécialisée dans la santé vasculaire et les solutions de traitement du cancer, a annoncé sa participation à la prochaine 35e Conférence Virtuelle Annuelle MedTech et Services d'Oppenheimer.
L'équipe de direction de l'entreprise, y compris le Président et CEO Jim Clemmer et le EVP/CFO Stephen Trowbridge, présentera une intervention le lundi 17 mars 2025, à 12h00 ET. Les investisseurs et les parties intéressées peuvent accéder au webinaire en direct via la section 'Investisseurs' du site web d'AngioDynamics à l'adresse www.angiodynamics.com, avec une option de rediffusion disponible après l'événement.
AngioDynamics (NASDAQ: ANGO), ein Medizintechnikunternehmen, das sich auf vaskuläre Gesundheit und Lösungen zur Krebsbehandlung spezialisiert hat, hat seine Teilnahme an der bevorstehenden 35. jährlichen virtuellen MedTech- und Dienstleistungskonferenz von Oppenheimer bekannt gegeben.
Das Führungsteam des Unternehmens, einschließlich Präsident und CEO Jim Clemmer sowie EVP/CFO Stephen Trowbridge, wird am Montag, den 17. März 2025, um 12:00 Uhr ET eine Präsentation halten. Investoren und interessierte Parteien können über den Bereich 'Investoren' auf der Website von AngioDynamics unter www.angiodynamics.com auf das Live-Webcast zugreifen, mit einer Wiederholungsoption, die nach der Veranstaltung verfügbar ist.
- None.
- None.
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250310753635/en/
Investors:
AngioDynamics, Inc.
Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408
Source: AngioDynamics, Inc.
FAQ
When is AngioDynamics (ANGO) presenting at the Oppenheimer Healthcare Conference 2025?
How can investors watch AngioDynamics' (ANGO) Oppenheimer Conference presentation?
Which AngioDynamics (ANGO) executives are presenting at the Oppenheimer Healthcare Conference?
What is the format of AngioDynamics' (ANGO) Oppenheimer Conference presentation?
